SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 16th, 2022 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 7, 2022, by and between H-CYTE INC., a Nevada corporation, with headquarters located at 2202 N. West Shore Blvd Ste 200 Tampa,FL 33607(the “Company”) and FAST CAPITAL, LLC, a Delaware limited liability company, with its address at 3763 Rosecroft Ct., San Diego, CA 92130, (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 16th, 2022 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 8, 2022, by and between H-Cyte, Inc., a Nevada corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
PROMISSORY NOTEPromissory Note • June 16th, 2022 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Nevada
This Note is delivered pursuant to the terms of that certain Securities Purchase Agreement (the “SPA”) of even date herewith, by and among H-Cyte, Inc. (the “Company” or the “Borrower”), and the Lender (the “Letter”). Capitalized terms used but not defined in this Note shall have the meanings ascribed to them in the Letter.
